Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection

NCT04488575 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient study defined patient population

Conditions

Covid19

Interventions

DRUG: EDP1815
DRUG: Placebo

Sponsor

Evelo Biosciences, Inc.